Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients (MPRvsMEL200)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00551928 |
Recruitment Status :
Active, not recruiting
First Posted : October 31, 2007
Last Update Posted : June 29, 2023
|
Sponsor:
Fondazione EMN Italy Onlus
Information provided by (Responsible Party):
Fondazione EMN Italy Onlus
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | June 2022 |
Estimated Study Completion Date : | June 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):